Tags

Type your tag names separated by a space and hit enter

Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.
J Clin Microbiol. 2006 Nov; 44(11):4227-8.JC

Abstract

We investigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime by utilizing the Etest. The MICs ranged from 0.094 microg/ml to 0.75 microg/ml, 0.094 microg/ml to 1.5 microg/ml, and 1 microg/ml to 12 microg/ml for ertapenem, meropenem, and cefepime, respectively. Based on our excellent in vitro carbapenem susceptibility results, in vivo studies using ertapenem and meropenem in a rabbit model of P. acnes endophthalmitis are warranted.

Links

Publisher Full Text
ncbi.nlm.nih.gov
jcm.asm.org
PMC Free PDF

Authors+Show Affiliations

Shames R
Division of Infectious Disease, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York 11042, USA.
Satti F
No affiliation info available
Vellozzi EM
No affiliation info available
Smith MA
No affiliation info available

MeSH

AnimalsAnti-Bacterial AgentsCefepimeCephalosporinsErtapenemEyeMeropenemMicrobial Sensitivity TestsPropionibacterium acnesRabbitsThienamycinsbeta-Lactams

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16971643

Citation

Shames, Robert, et al. "Susceptibilities of Propionibacterium Acnes Ophthalmic Isolates to Ertapenem, Meropenem, and Cefepime." Journal of Clinical Microbiology, vol. 44, no. 11, 2006, pp. 4227-8.
Shames R, Satti F, Vellozzi EM, et al. Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime. J Clin Microbiol. 2006;44(11):4227-8.
Shames, R., Satti, F., Vellozzi, E. M., & Smith, M. A. (2006). Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime. Journal of Clinical Microbiology, 44(11), 4227-8.
Shames R, et al. Susceptibilities of Propionibacterium Acnes Ophthalmic Isolates to Ertapenem, Meropenem, and Cefepime. J Clin Microbiol. 2006;44(11):4227-8. PubMed PMID: 16971643.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime. AU - Shames,Robert, AU - Satti,Farhana, AU - Vellozzi,Ernestine M, AU - Smith,Miriam A, Y1 - 2006/09/13/ PY - 2006/9/15/pubmed PY - 2006/12/23/medline PY - 2006/9/15/entrez SP - 4227 EP - 8 JF - Journal of clinical microbiology JO - J Clin Microbiol VL - 44 IS - 11 N2 - We investigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime by utilizing the Etest. The MICs ranged from 0.094 microg/ml to 0.75 microg/ml, 0.094 microg/ml to 1.5 microg/ml, and 1 microg/ml to 12 microg/ml for ertapenem, meropenem, and cefepime, respectively. Based on our excellent in vitro carbapenem susceptibility results, in vivo studies using ertapenem and meropenem in a rabbit model of P. acnes endophthalmitis are warranted. SN - 0095-1137 UR - https://www.unboundmedicine.com/medline/citation/16971643/Susceptibilities_of_Propionibacterium_acnes_ophthalmic_isolates_to_ertapenem_meropenem_and_cefepime_ L2 - http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=16971643 DB - PRIME DP - Unbound Medicine ER -
Grapherence [↓2 ↑8]

Related Citations

More